Literature DB >> 29421693

Enhanced Recovery after Colorectal Surgery: Can We Afford Not to Use It?

Andrew D Jung1, Vikrom K Dhar1, Richard S Hoehn1, Sarah J Atkinson1, Bobby L Johnson1, Teresa Rice1, Jonathan R Snyder2, Janice F Rafferty2, Michael J Edwards2, Ian M Paquette3.   

Abstract

BACKGROUND: Enhanced recovery pathways (ERPs) aim to reduce length of stay without adversely affecting short-term outcomes. High pharmaceutical costs associated with ERP regimens, however, remain a significant barrier to widespread implementation. We hypothesized that ERP would reduce hospital costs after elective colorectal resections, despite the use of more expensive pharmaceutical agents. STUDY
DESIGN: An ERP was implemented in January 2016 at our institution. We collected data on consecutive colorectal resections for 1 year before adoption of ERP (traditional, n = 160) and compared them with consecutive resections after universal adoption of ERP (n = 146). Short-term surgical outcomes, total direct costs, and direct hospital pharmacy costs were compared between patients who received the ERP and those who did not.
RESULTS: After implementation of the ERP, median length of stay decreased from 5.0 to 3.0 days (p < 0.01). There were no differences in 30-day complications (8.1% vs 8.9%) or hospital readmission (11.9% vs 11.0%). The ERP patients required significantly less narcotics during their index hospitalization (211.7 vs 720.2 morphine equivalence units; p < 0.01) and tolerated a regular diet 1 day sooner (p < 0.01). Despite a higher daily pharmacy cost ($477 per day vs $318 per day in the traditional cohort), the total direct pharmacy cost for the hospitalization was reduced in ERP patients ($1,534 vs $1,859; p = 0.016). Total direct cost was also lower in ERP patients ($9,791 vs $11,508; p = 0.004).
CONCLUSIONS: Implementation of an ERP for patients undergoing elective colorectal resection substantially reduced length of stay, total hospital cost, and direct pharmacy cost without increasing complications or readmission rates. Enhanced recovery pathway after colorectal resection has both clinical and financial benefits. Widespread implementation has the potential for a dramatic impact on healthcare costs.
Copyright © 2018 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29421693     DOI: 10.1016/j.jamcollsurg.2017.12.031

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  3 in total

1.  Reduction of opioid use after implementation of enhanced recovery after bariatric surgery (ERABS).

Authors:  Pearl Ma; Aaron Lloyd; Morgan McGrath; Riley Moore; Alice Jackson; Keith Boone; Kelvin Higa
Journal:  Surg Endosc       Date:  2019-07-24       Impact factor: 4.584

2.  Cost-effectiveness comparisons of enhanced recovery after surgery (ERAS) vs. non-ERAS for esophageal cancer in China: a retrospective comparative cohort study.

Authors:  Meng Zhang; Hong Wang; Xiaoyang Wang; Luyao Zhang; Cong Shen; Caihua Tian; Xiaoxia Xu; Xiang Li; Zongze Li; Shao-Kai Zhang; Bin-Bin Han
Journal:  Ann Transl Med       Date:  2022-09

3.  Enhanced recovery protocol improves postoperative outcomes and minimizes narcotic use following resection for colon and rectal cancer.

Authors:  Alexander R Cortez; Al-Faraaz Kassam; Nick C Levinsky; Andrew D Jung; Meghan C Daly; Shimul A Shah; Janice F Rafferty; Ian M Paquette
Journal:  Surg Open Sci       Date:  2019-07-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.